EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Activity
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

164 hedge funds and large institutions have $633M invested in Eagle Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 68 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
-4
Holders Change %
-2.38%
% of All Funds
3.37%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
55
Reduced
68
Closed
22
Calls
$983K
Puts
$388K
Net Calls
+$595K
Net Calls Change
+$3.39M

Top Buyers

1
AC
Armistice Capital
New York
+$13.5M
2
Citadel Advisors
Citadel Advisors
Florida
+$9.02M
3
State Street
State Street
Massachusetts
+$7.4M
4
Invesco
Invesco
Georgia
+$7.29M
5
Millennium Management
Millennium Management
New York
+$5.09M

Top Sellers

1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$11.4M
2
Goldman Sachs
Goldman Sachs
New York
-$9.88M
3
LSV Asset Management
LSV Asset Management
Illinois
-$7.28M
4
BIP
Brandes Investment Partners
California
-$6.88M
5
GC
Guggenheim Capital
Illinois
-$5.76M
Name Holding Trade Value Shares
Change 		Shares
Change %
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$4.49M +$1.46M +30,389 +48%
AQR Capital Management
27
AQR Capital Management
Connecticut
$4.42M -$2.52M -52,418 -36%
Russell Investments Group
28
Russell Investments Group
United Kingdom
$4.29M +$1.15M +24,040 +37%
Principal Financial Group
29
Principal Financial Group
Iowa
$4.15M -$11.9K -249 -0.3%
Ameriprise
30
Ameriprise
Minnesota
$4.11M -$3.41K -71 -0.1%
SI
31
Scout Investments
Missouri
$4.05M -$18.5K -386 -0.5%
FP
32
Foundry Partners
Minnesota
$3.6M -$456K -9,504 -11%
Bank of America
33
Bank of America
North Carolina
$3.52M -$488K -10,182 -12%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$3.37M -$250K -5,205 -7%
Charles Schwab
35
Charles Schwab
California
$3.27M +$386K +8,047 +13%
Man Group
36
Man Group
United Kingdom
$3.22M -$77K -1,605 -2%
PAMU
37
Pictet Asset Management (UK)
United Kingdom
$3.18M -$872K -18,181 -22%
JPMorgan Chase & Co
38
JPMorgan Chase & Co
New York
$3.09M -$187K -3,903 -6%
MCM
39
Matarin Capital Management
New York
$2.83M -$1.41M -29,296 -33%
MAM
40
Martingale Asset Management
Massachusetts
$2.82M +$149K +3,100 +6%
SG Americas Securities
41
SG Americas Securities
New York
$2.71M +$969K +20,193 +56%
William Blair & Company
42
William Blair & Company
Illinois
$2.56M +$2.4K +50 +0.1%
Morgan Stanley
43
Morgan Stanley
New York
$2.45M +$85.1K +1,773 +4%
Nuveen Asset Management
44
Nuveen Asset Management
Illinois
$2.43M +$301K +6,276 +14%
CTA
45
Carillon Tower Advisers
Florida
$2.41M -$57.6K -1,200 -2%
JIM
46
Jupiter Investment Management
United Kingdom
$2.32M -$1.69M -35,275 -42%
Capital Fund Management (CFM)
47
Capital Fund Management (CFM)
France
$2.32M -$1.35M -28,138 -37%
Aviva
48
Aviva
United Kingdom
$2.28M -$1.77M -36,882 -44%
CAM
49
ClariVest Asset Management
California
$2.23M +$37.4K +780 +2%
Los Angeles Capital Management
50
Los Angeles Capital Management
California
$2.2M +$656K +13,681 +43%
1
2
3 4 5